THAM (Hospira, Inc.)


Welcome to the PulseAid listing for the THAM drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: TROMETHAMINE
SUBSTANCE NAME: TROMETHAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-11-16
END MARKETING DATE: 0000-00-00


THAM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTHAM from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3.6(g/100mL)
START MARKETING DATE: 2009-11-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1593_96fa446d-d34d-4ea7-9f09-b34ffe0f9bf6
PRODUCT NDC: 0409-1593
APPLICATION NUMBER: NDA013025

Other TROMETHAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.THAM